Younossi ZM, Stepanova M, Charlton M, Curry MP, O'Leary JG, Brown RS, Hunt S. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet Gastroenterol Hepatol 2016;1:122-32. [PMID: 28404069 DOI: 10.1016/S2468-1253(16)30009-7][Cited by in Crossref: 49][Cited by in F6Publishing: 11][Article Influence: 8.2][Reference Citation Analysis]